Development of a vaccine for the prevention of AIDS, a critical appraisal
- 31 December 1992
- Vol. 10 (14), 1039-1052
- https://doi.org/10.1016/0264-410x(92)90114-y
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Synergistic Neutralization of HIV-1 by Human Monoclonal Antibodies Against the V3 Loop and the CD4-Binding Site of gp120AIDS Research and Human Retroviruses, 1992
- Synergy Between Human Monoclonal Antibodies to HIV Extends Their Effective Biologic Activity Against Homologous and Divergent StrainsAIDS Research and Human Retroviruses, 1992
- The Emergence of Simian/Human Immunodeficiency VirusesAIDS Research and Human Retroviruses, 1992
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1991
- High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 InfectionNew England Journal of Medicine, 1991
- Peptide Component Vaccine Engineering: Targeting the AIDS VirusInternational Reviews of Immunology, 1990
- pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneCell, 1987
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984